Home › Funds › UBS Group AG › IPA
UBS Group AG position in IPA
IMMUNOPRECISE ANTIBODIES LTD
Latest position (Q2 2025)6.27K sh
Reported value held$6.64K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.00K | $18.00K | New |
| Q4 2021 | 3.99K | $21.00K | Add |
| Q2 2022 | 3.60K | $14.00K | New |
| Q3 2022 | 30 | $0 | Reduce |
| Q4 2022 | 1.59K | $8.27K | Add |
| Q3 2023 | 70 | $128 | New |
| Q4 2023 | 10.68K | $18.26K | Add |
| Q1 2024 | 2.48K | $3.77K | Reduce |
| Q2 2024 | 12.23K | $12.35K | Add |
| Q1 2025 | 7.56K | $2.85K | New |
| Q2 2025 | 6.27K | $6.64K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.